Acumen Pharmaceuticals Inc. (ABOS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Acumen Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$2.38
+5.31% today
Market cap
$163M
Overall quality
37/100
Kronos AI 30-day
+6.2%
7 of 8 simulated paths end higher
Acumen Pharmaceuticals Inc. (ABOS) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $163M. It trades at $2.38, up 5.31% today. Its overall quality score is 37 out of 100, ranked against the whole US market. 3 analysts' average target of $7.00 implies +194.1% from today's price. Kronos AI's 30-day forecast is +6.2% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.00 |
| Low – high | $5.00 – $8.00 |
| Analysts | 3 |
| Upside to average | +194.1% |
Kronos AI 30-day forecast
| Expected close | $2.40 (+6.2%) |
| Likely range | −0.2% … +23.4% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 43 |
| Growth | 31 |
| Overall | 37 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.